Quantcast
Last updated on April 17, 2014 at 9:29 EDT

Cantel Medical To Present At 15th Annual Needham Growth Conference

January 7, 2013

LITTLE FALLS, N.J., Jan. 7, 2013 /PRNewswire/ — CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Needham 15(th) Annual Growth Conference. The formal presentation is scheduled for 2:50 PM ET on Thursday, January 17, 2013 at The New York Palace Hotel, with a Q & A session immediately following the presentation. In addition, Mr. Krakauer and Seth Yellin, Vice President-Corporate Development, will be available for separate one-on-one meetings during the day. The presentation will be available on the Investor Relations section of the Company’s website: www.cantelmedical.com.

About Cantel Medical Corp.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com.

SOURCE Cantel Medical Corp.


Source: PR Newswire